Esomeprazole Magnesium
Product Images NDC 68788-6922

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68788-6922). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (20973b5f 8ee5 47e7 Bbf6 4ab55db8dd7d 01)

Chemical structure of Esomeprazole Magnesium showing two Esomeprazole molecules complexed with a magnesium ion (Mg2+). The structure includes pyridine and benzimidazole rings with methoxy and methyl substituents and a sulfinyl group linking components.*

FDA Label Image

Figure 1 (20973b5f 8ee5 47e7 Bbf6 4ab55db8dd7d 02)

A line graph showing the percent maintained over six months for different doses of Esomeprazole Magnesium (40 mg, 20 mg, 10 mg) compared to placebo. The y-axis represents percent maintained ranging from 0 to 100%, and the x-axis represents time in months with scheduled visits indicated. Higher doses of Esomeprazole Magnesium maintain a higher percentage over time compared to placebo.*

FDA Label Image

Figure 3 (20973b5f 8ee5 47e7 Bbf6 4ab55db8dd7d 03)

A line graph depicting percent mean fundus filled over a six-month period with scheduled visits. It compares Esomeprazole Magnesium at 40 mg, 20 mg, and 10 mg doses, and placebo. The 40 mg dose maintains near 100%, while lower doses and placebo show decreasing trends over time.*

FDA Label Image

Figure (20973b5f 8ee5 47e7 Bbf6 4ab55db8dd7d 04)

A line graph showing the percent of Pfizer's Sigmoidoscopy-Free patients over a 28-day period for three groups: Esomeprazole Magnesium 40 mg, Esomeprazole Magnesium 20 mg, and Placebo. The x-axis represents diary days, and the y-axis represents the percentage of patients.*

FDA Label Image

Figure (20973b5f 8ee5 47e7 Bbf6 4ab55db8dd7d 05)

A line graph showing the percent of placebo symptom-free patients over 28 days comparing Esomeprazole Magnesium 40mg, Esomeprazole Magnesium 20mg, and placebo. The x-axis represents days from 0 to 28, and the y-axis shows the percent of symptom-free patients from 0% to 100%.*

FDA Label Image

Logo (20973b5f 8ee5 47e7 Bbf6 4ab55db8dd7d 06)

FDA Label Image

Image (20973b5f 8ee5 47e7 Bbf6 4ab55db8dd7d 07)

FDA Label Image

Esomeprazole Magnesium Delayed Release Capsules 40mg (20973b5f 8ee5 47e7 Bbf6 4ab55db8dd7d 08)

Label for Esomeprazole Magnesium Delayed-Release Capsules 40 mg by Preferred Pharmaceuticals Inc., Anaheim, CA. The label includes usage directions in English and Spanish, dosing instructions, and manufacturer details (Torrent Pharmaceuticals Limited). It also contains warnings, lot, batch, and expiration placeholders, and states the product is generic for Nexium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.